Breakthroughs and Innovations: Managing Complex Cases in Graft-versus-Host Disease - a podcast by ReachMD

CME credits: 0.50

Valid until: 17-12-2021

Claim your CME credit at https://reachmd.com/programs/cme/breakthroughs-innovations-managing-complex-cases-in-graft-versus-host-disease/11883/

Acute graft-versus-host disease (aGVHD) is a common complication of allogeneic hematopoietic stem cell transplantation and is a major cause of morbidity and mortality. Although systemic corticosteroids are traditional first-line treatment for aGVHD, about half of patients are refractory to therapy. So what options are available for the treatment of steroid-refractory aGVHD?

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD